» Articles » PMID: 33447822

Utilizing Glycoside Hydrolases to Improve the Quantitation and Visualization of Biofilm Bacteria

Overview
Journal Biofilm
Date 2021 Jan 15
PMID 33447822
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The complexity of microbial biofilms offers several challenges to the use of traditional means of microbial research. In particular, it can be difficult to calculate accurate numbers of biofilm bacteria, because even after thorough homogenization or sonication, small pieces of the biofilm remain, which contain numerous bacterial cells and result in inaccurately low colony forming units (CFU). In addition, imaging of infected tissue often results in a disparity between the CFU and the number of bacterial cells observed under the microscope. We hypothesized that this phenomenon is due to the biofilm extracellular polymeric substance decreasing the accessibility of stains and antibodies to the embedded bacterial cells. In this study, we describe incorporating EPS-degrading glycoside hydrolases for CFU determination to obtain a more accurate estimation of the viable cells and for immunohistochemistry to disrupt the biofilm matrix and increase primary antibody binding to the bacterial cells.

Citing Articles

Perspective: The viscoelastic properties of biofilm infections and mechanical interactions with phagocytic immune cells.

Wells M, Schneider R, Bhattarai B, Currie H, Chavez B, Christopher G Front Cell Infect Microbiol. 2023; 13:1102199.

PMID: 36875516 PMC: 9978752. DOI: 10.3389/fcimb.2023.1102199.


3D spatial organization and improved antibiotic treatment of a wound biofilm by nanoparticle enzyme delivery.

Rubio-Canalejas A, Baelo A, Herbera S, Blanco-Cabra N, Vukomanovic M, Torrents E Front Microbiol. 2022; 13:959156.

PMID: 36466653 PMC: 9708873. DOI: 10.3389/fmicb.2022.959156.


Contribution of Exopolysaccharides Pel and Psl to Wound Infections.

Fleming D, Niese B, Redman W, Vanderpool E, Gordon V, Rumbaugh K Front Cell Infect Microbiol. 2022; 12:835754.

PMID: 35463635 PMC: 9021892. DOI: 10.3389/fcimb.2022.835754.


In vitro activities of cellulase and ceftazidime, alone and in combination against Pseudomonas aeruginosa biofilms.

Kamali E, Jamali A, Izanloo A, Ardebili A BMC Microbiol. 2021; 21(1):347.

PMID: 34915848 PMC: 8675527. DOI: 10.1186/s12866-021-02411-y.

References
1.
Fleming D, Chahin L, Rumbaugh K . Glycoside Hydrolases Degrade Polymicrobial Bacterial Biofilms in Wounds. Antimicrob Agents Chemother. 2016; 61(2). PMC: 5278739. DOI: 10.1128/AAC.01998-16. View

2.
Coico R . Gram staining. Curr Protoc Microbiol. 2008; Appendix 3:Appendix 3C. DOI: 10.1002/9780471729259.mca03cs00. View

3.
Wolcott R, Rumbaugh K, James G, Schultz G, Phillips P, Yang Q . Biofilm maturity studies indicate sharp debridement opens a time- dependent therapeutic window. J Wound Care. 2010; 19(8):320-8. DOI: 10.12968/jowc.2010.19.8.77709. View

4.
Rogers S, Huigens 3rd R, Cavanagh J, Melander C . Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents. Antimicrob Agents Chemother. 2010; 54(5):2112-8. PMC: 2863642. DOI: 10.1128/AAC.01418-09. View

5.
Koo H, Allan R, Howlin R, Stoodley P, Hall-Stoodley L . Targeting microbial biofilms: current and prospective therapeutic strategies. Nat Rev Microbiol. 2017; 15(12):740-755. PMC: 5685531. DOI: 10.1038/nrmicro.2017.99. View